Retrospective Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 18, 2021; 11(12): 512-522
Published online Dec 18, 2021. doi: 10.5500/wjt.v11.i12.512
Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area
Isabela Dias Lauar, Luciana Costa Faria, Roberta Maia de Castro Romanelli, Wanessa Trindade Clemente
Isabela Dias Lauar, Medicine Department, Universidade José do Rosário Vellano, Belo Horizonte 31710030, Minas Gerais, Brazil
Luciana Costa Faria, Internal Medicine Department, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 30130100, Minas Gerais, Brazil
Roberta Maia de Castro Romanelli, Pediatrics Department, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 30130100, Minas Gerais, Brazil
Wanessa Trindade Clemente, Department of Laboratory Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte 30130100, Minas Gerais, Brazil
Author contributions: Lauar ID, Faria LC, Romanelli RMC and Clemente WT contributed equally to this work in every aspect of study design, data collection and analysis, and manuscript preparation.
Institutional review board statement: The study was approved by the Federal University of Minas Gerais Research Ethics Committee (approval number: 0614.0.203.000-11).
Informed consent statement: All participants provided informed written consent about use of their data in the study and signed the Informed Consent Term.
Conflict-of-interest statement: The authors declare there is no potential conflict-of-interest in this study.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Isabela Dias Lauar, MD, Doctor, Professor, Medicine Department, Universidade José do Rosário Vellano, Rua Líbano, 66-Itapoã, Belo Horizonte 31710030, Minas Gerais, Brazil. belalauar@yahoo.com.br
Received: July 26, 2021
Peer-review started: July 26, 2021
First decision: September 2, 2021
Revised: September 25, 2021
Accepted: November 14, 2021
Article in press: November 14, 2021
Published online: December 18, 2021
Processing time: 140 Days and 16.5 Hours
ARTICLE HIGHLIGHTS
Research background

In solid organ transplants, one should be aware of the potential risk for tuberculosis, usually because reactivation of latent tuberculosis infection (LTBI).

Research motivation

Dealing with tuberculosis risk is especially difficult in countries with high endemic rates. In liver transplant recipients, we also have to deal with hepatotoxicity associated with the treatment regimens for LTBI.

Research objectives

The aim of this study was to evaluate the frequency of LTBI in liver transplant patients and treatment-related issues.

Research methods

This is a retrospective analysis of a cohort of cirrhotic patients aged ≥ 18 years who underwent liver transplantation at a high-complexity teaching hospital from January 2005 to December 2012. LTBI diagnosis and treatment were analyzed.

Research results

The prevalence of LTBI was lower than expected, probably due to low TST sensitivity in patients with impaired liver function. In addition, the initiation and completion of LTBI was limited by difficulties in the management of patients in the presence of elevated liver enzymes and a potential risk of hepatotoxicity.

Research conclusions

The prevalence of LTBI was lower than expected, and the initiation and completion of LTBI treatment was limited by difficulties in the management of these special patients.

Research perspectives

It is necessary to search for other criteria to indicate the treatment of LTBI for patients submitted to liver transplantation, and further research is necessary to develop an effective and well-tolerated alternative therapeutic strategy for LTBI.